MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,476,984 | -31.1% | 7,747,891 | -26.9% | 0.11% | -28.9% |
Q4 2022 | $7,954,142 | -12.9% | 10,605,522 | 0.0% | 0.15% | -10.6% |
Q3 2022 | $9,132,000 | -16.0% | 10,605,522 | +9.2% | 0.17% | -13.7% |
Q2 2022 | $10,877,000 | -43.7% | 9,711,422 | -43.8% | 0.20% | -37.1% |
Q1 2022 | $19,336,000 | -30.0% | 17,264,764 | 0.0% | 0.31% | -11.8% |
Q4 2021 | $27,624,000 | -33.9% | 17,264,764 | 0.0% | 0.36% | -22.7% |
Q3 2021 | $41,781,000 | -23.7% | 17,264,764 | 0.0% | 0.46% | -17.1% |
Q2 2021 | $54,730,000 | -5.9% | 17,264,764 | +0.0% | 0.55% | +1.8% |
Q1 2021 | $58,183,000 | +17.6% | 17,264,763 | +25.0% | 0.54% | +25.6% |
Q4 2020 | $49,463,000 | – | 13,816,488 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,972,958 | $4,775,000 | 1.26% |
Altium Capital Management LP | 1,250,000 | $3,025,000 | 0.79% |
Rubric Capital Management LP | 11,300,000 | $27,346,000 | 0.76% |
Vivo Capital, LLC | 6,907,189 | $16,715,000 | 0.75% |
DAFNA Capital Management LLC | 1,126,613 | $2,726,000 | 0.72% |
SILVERARC CAPITAL MANAGEMENT, LLC | 365,661 | $885,000 | 0.50% |
Orbimed Advisors | 17,264,764 | $41,781,000 | 0.46% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $621,000 | 0.45% |
Endurant Capital Management LP | 746,514 | $1,807,000 | 0.41% |
Affinity Asset Advisors, LLC | 650,000 | $1,573,000 | 0.40% |